Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review.
AIMS/HYPOTHESIS: Diabetes treatments were related with either an increased or reduced risk of cancer. There is ongoing debate about a potential protective action of metformin. To summarize evidence on the association between metformin and risk of cancer and cancer mortality in patients with diabetes...
Main Authors: | Monica Franciosi, Giuseppe Lucisano, Emanuela Lapice, Giovanni F M Strippoli, Fabio Pellegrini, Antonio Nicolucci |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3732236?pdf=render |
Similar Items
-
Variability in body weight and the risk of cardiovascular complications in type 2 diabetes: results from the Swedish National Diabetes Register
by: Antonio Ceriello, et al.
Published: (2021-08-01) -
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk
by: Luca Miele, et al.
Published: (2015-01-01) -
The Effect of Metformin as an Adjunct Therapy in Adolescents with Type 1 Diabetes
by: Aria Setoodeh, et al.
Published: (2017-04-01) -
Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus
by: Tian Li, et al.
Published: (2021-01-01) -
Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
by: Jixue Tan, et al.
Published: (2021-05-01)